|
MINISTRY OF HEALTH
|
SOCIALIST
REPUBLIC OF VIETNAM |
|
No. 490/QD-QLD |
Hanoi, August 24, 2021 |
DIRECTOR OF DRUG ADMINISTRATION OF VIETNAM
Pursuant to the Law on Pharmaceuticals No. 105/2016/QH13 dated April 6, 2016;
Pursuant to Decree No. 75/2017/ND-CP dated June 20, 2017 of the Government on functions, tasks, powers, and organizational structure of the Ministry of Health;
Pursuant to Decision No. 7868/QD-BYT dated December 28, 2018 of Minister of Health on functions, tasks, powers and organizational structure of Drug Administration of Vietnam affiliated to Minister of Health;
Pursuant to Circular No. 32/2018/TT-BYT dated November 12, 2018 of the Minister of Health promulgating medicine and medicinal ingredient marketing registration;
Pursuant to Circular No. 29/2020/TT-BYT dated December 31, 2020 of the Minister of Health on amendment and annulment of several legislative documents promulgated or jointly promulgated by the Minister of Health.
Pursuant to remarks of the Advisory Council for medicine and medicinal ingredient marketing authorization - Ministry of Health;
At request of the Director of Drug Registration Department - Drug Administration of Vietnam,
HEREBY DECIDES:
Article 1. The list of 83 foreign medicines licensed for marketing authorization - the 2nd amendment of the 105th edition is attached hereto, including:
1. The list of 66 foreign medicines issued with marketing authorization that remains effective for 5 years - 2nd revision of the 105th edition (under Appendix I attached hereto). Medicines under this list are registered under code VN-…-21 and remain effective for 5 years from the date on which this Decision is promulgated.
2. The list of 15 foreign medicines issued with marketing authorization that remains effective for 3 years - 2nd revision of the 105th edition (under Appendix II attached hereto). Medicines under this list are registered under code VN3-…-21 and remain effective for 3 years from the date on which this Decision is promulgated.
Article 2. Drug manufacturing facilities and drug registering facilities are responsible for:
1. Importing medicines into Vietnam in accordance with document registered with the Ministry of Health and printing or fixing registration number issued by the Ministry of Health on the medicine label.
2. Fully complying with regulations of the Socialist Republic of Vietnam and the Ministry of Health pertaining to medicine import and circulation; immediately reporting to the Drug Administration of Vietnam - Ministry of Health in case of any change to drug circulation process in host countries and in Vietnam.
3. Updating medicine quality standards in accordance with Circular No. 11/2018/TT-BYT dated May 4, 2018 of the Minister of Health.
4. Updating medicine labels and package inserts in accordance with Circular No. 01/2018/TT-BYT dated January 18, 2018 of the Minister of Health depending on method of revising medicine marketing authorization in accordance with Circular No. 32/2018/TT-BYT dated November 12, 2018 of the Minister of Health for medicine whose labels and package inserts have not been updated in accordance with Circular No. 01/2018/TT-BYT dated January 18, 2018 of the Minister of Health, to be specific:
a) With respect to medicines named under the list of toxic medicines and toxic medicinal ingredients under Circular No. 06/2017/TT-BYT dated May 3, 2017 of the Minister of Health: only allowed for marketing after obtaining approval of the Drug Administration of Vietnam for this update.
b) With respect to other medicines, update within 6 months from the date on which marketing authorization is issued.
5. Cooperating with treatment facilities in adequately adhering to applicable regulations on prescription drugs, monitoring safety, efficacy, adverse effects of medicine on Vietnamese people, consolidating, reporting in accordance with Article 5 of Circular No. 32/2018/TT-BYT dated January 12, 2018 of the Minister of Health for medicines under the list in Appendix II attached hereto (registration under code VN3-…-21).
6. Registration facilities must maintain their operation conditions during effective period of the medicine and medicinal ingredient marketing authorization. If failing to meet operation conditions, registration facilities are responsible for changing registration facilities in accordance with Circular No. 32/2018/TT-BYT dated November 12, 2018 of the Minister of Health within 30 days from the date on which the registration facilities no longer meet operation conditions.
7. Registration facilities must submit reports on compliance with Good Manufacturing Practice of medicine, medicinal ingredient manufacturing facilities. If manufacturing facilities have their license revoked or fail to meet GMP for medicine and medicinal ingredients in host countries, the facilities must submit reports within 15 days from the date on which they receive notice from a competent body of the host countries in accordance with Point d Clause 1 Article 100 of the Decree No. 54/2017/ND-CP dated May 8, 2017 of the Government.
Article 3. This Decision comes into effect from the day of signing.
Article 4. Directors of Departments of Health of provinces and central-affiliated cities, directors of manufacturing facilities and registration facilities whose operations involvement medicine under Article 1 are responsible for the implementation of this Decision./.
|
|
DIRECTOR |
LIST OF 66 FOREIGN MEDICINES ISSUED WITH MARKETING
AUTHORIZATION FOR 5 YEARS - 2ND REVISION OF THE 105TH
EDITION
(Attached to Decision No. 490/QD-QLD, dated August 4, 2021)
1. Applicant: Accord Healthcare Limited (Address: Ground Floor, Sage House, 319 Pinner Road, North Harrow, Middlesex HA1 4HF - United Kingdom)
1.1 Manufacturer: Intas Pharmaceuticals Ltd (Address: Plot No. 457, 458, Village-Matoda, Bavla Road, And Plot No: 191/218 P, Village: Chacharwadi,Ta:-Sanand, Dist. -Ahmedabad - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
1 |
C-Flox 500 |
Ciprofloxacin (in form of Ciprofloxacin hydrochloride) 500mg |
Film coated tablet |
36 months |
USP41 |
10 packs x 10 tablets container |
VN-22804-21 |
2. Applicant: Alleviare Life Sciences Private Limited (Address: S - 1/5 First Floor, Uphaar Cinema Complex Market, Green Park Extention, New Delhi, South Delhi, DL 110016 - India)
2.1 Manufacturer Icpa Health Products Limited (Address: 286/287/288, GIDC, Ankleshwar-393002, Dist. Bharuch, Gujarat state - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
2 |
Hexidine |
Chlorhexidine gluconate 2% (w/v) |
Mouthwash |
36 months |
NSX |
80 ml bottle |
VN-22805-21 |
3. Applicant: Ambica International Corporation (Address: 9 Amsterdam Extension, Merville park Subd, Paranaque City - Philippines)
3.1 Manufacturer: Nobel Ilac Sanayii Ve Ticaret A.S. (Address: Sancaklar Mah. Eski Akcakoca, Cad. No: 299 81100 Duzce - Turkey)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
3 |
Vesifix 10 mg Film Coated Tablet |
Solifenacin succinat 10mg |
Film coated tablet |
24 months |
NSX |
3 packs x 10 tablets container |
VN-22806-21 |
|
4 |
Vesifix 5 mg Film Coated Tablet |
Solifenacin succinat 5mg |
Film coated tablet |
24 months |
NSX |
3 packs x 10 tablets container |
VN-22807-21 |
4. Applicant: AR Tradex Pvt. Ltd. (Address: Unit No. 11 Block H, Wegmans Prinston Plaza, Sector 18, Rohini, North West Delhi 110089 IN - India)
4.1 Manufacturer: Globela Pharma Pvt. Ltd (Address: 357, GIDC, Sachin, City: Surat-394 230, Dist: Gujarat State - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
5 |
Gidover 16 |
Betahistine dihydrocloride 16 mg |
Tablet |
36 months |
BP 2017 |
10 packs x 10 tablets container |
VN-22808-21 |
|
6 |
Gidover 24 |
Betahistine dihydrocloride 24 mg |
Tablet |
36 months |
BP 2017 |
10 packs x 10 tablets container |
VN-22809-21 |
|
7 |
Gidover 8 |
Betahistine dihydrocloride 8 mg |
Tablet |
36 months |
BP 2017 |
10 packs x 10 tablets container |
VN-22810-21 |
5. Applicant: Aurobindo Pharma Limited (Address: Plot No. 2, Maitrivihar, Ameerpet, Hyderabad - 500 038, Telangana State - India)
5.1 Manufacturer: Auronext Pharma Private Limited (Address: A-1128, Phase-III, RIICO Industrial Area, Bhiwadi - 301019, District- Alwar, Rajasthan - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
8 |
Inemplus 250 |
Each powder container contains: Imipenem 250mg; Cilastatin (in form of Cilastatin natri) 250mg |
Powder for reconstitution |
24 months |
USP 39 |
1 bottle container |
VN-22811-21 |
|
9 |
Inemplus 500 |
Each powder container contains: Imipenem 500mg; Cilastatin (in form of Cilastatin natri) 500mg |
Powder for reconstitution |
24 months |
USP 39 |
1 bottle container |
VN-22812-21 |
|
10 |
Meroauro 1000 |
Each powder container contains: Meropenem 1000mg |
Powder for reconstitution |
24 months |
USP 39 |
1 bottle container |
VN-22813-21 |
|
11 |
Meroauro 500 |
Each powder container contains: Meropenem 500mg |
Powder for reconstitution |
24 months |
USP 39 |
1 bottle container |
VN-22814-21 |
6. Applicant: Duoc Dai Nam Joint Stock Company (Address: 270A Ly Thuong Kiet, Ward 14, District 10, Ho Chi Minh City - Vietnam)
6.1 Manufactuer: Laboratorios Normon, S.A. (Address: Ronda de Valdecarrizo, 6,Tres Cantos, 28760 Madrid - Spain)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
12 |
Pramipexol Normon 0,18 mg Tablets |
Pramipexol (in form of dihydrochloride monohydrate) 0,18mg |
Tablet |
36 months |
NSX |
10 packs x 10 tablets container |
VN-22815-21 |
|
13 |
Pramipexol Normon 0,7 mg Tablets |
Pramipexol (in form of dihydrochloride monohydrate) 0,7 mg |
Tablet |
36 months |
NSX |
10 packs x 10 tablets container |
VN-22816-21 |
7. Applicant: Vietnam MK Pharmaceutical Joint Stock Company (Address: Plot No. 42, Land area No. TT-A2, urban area of Giao Luu City, Co Nhue Ward, Bac Tu Lien District, Hanoi - Vietnam)
7.1 Manufacturer: Limited Liability Company “Pharmaceutical company “Zdorovye” (Address: 22,Shevchenko str., Kharkiv, 61013, Kharkiv Region - Ukraine)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
14 |
Zudcil 200 |
Fluconazol 200mg |
Hard capsules |
60 months |
NSX |
1 pack x 7 tablets container |
VN-22817-21 |
7.2 Manufacturer: Ltd Farmaprim (Address: 5, Crinilor street, Porumbeni, Criuleni District, MD-4829 - Moldova)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
15 |
Dexidex |
Diclofenac natri 50mg |
Rectal suppositories |
36 months |
NSX |
1 pack x 6 tablets container |
VN-22818-21 |
8. Applicant: Hanoi Pharmaceutical Joint Stock Company (Address: 170 La Thanh Road, O Cho Dua Ward, Dong Da District, Hanoi - Vietnam)
8.1 Manufacturer: Nichi-Iko Pharmaceutical Co., Ltd. Aichi Plant (Address: 1212 Aza-teramae, Gejo-cho, kasugai-shi, Aichi - Japan)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
16 |
NIKP-Citicolin injection 500mg/2ml |
Every 2ml of solution contains: Citicolin 500mg |
Injection liquid |
36 months |
NSX |
50 tubes x 2 ml container |
VN-22819-21 |
9. Applicant: Minh Ky Pharmaceutical Joint Stock Company (Address : 1-3, Block C, Lac Long Quan Apartment building, Ward 5, District 11, Ho Chi Minh City - Vietnam)
9.1 Manufacturer: World Medicine Ilac San. ve Tic. A. S. (Address: 15 Temmuz Mah. Cami Yolu Cad. No 50, Güneşli, Bagcilar/ Istanbul - Turkey)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
17 |
Choludexan 300mg |
Acid ursodeoxycholic 300mg |
Hard capsules |
36 months |
NSX |
2 packs x 10 tablets container |
VN-22820-21 |
|
18 |
Pompezo 20mg |
Esomeprazol (in form of microparticle Esomeprazol magnesi dihydrat) 20mg |
Hard capsules |
24 months |
NSX |
4 packs x 7 tablets container |
VN-22821-21 |
|
19 |
Pompezo 40mg |
Esomeprazol (in form of microparticle Esomeprazol magnesi dihydrat) 40mg |
Hard capsules |
24 months |
NSX |
4 packs x 7 tablets container |
VN-22822-21 |
10. Applicant: C.A.T Pharmaceutical and Medical Equipment Joint Stock Company (Address: Trang Hamlet, Thanh Liet Ward, Thanh Tri District, Hanoi - Vietnam)
10.1 Manufacturer: Theon Pharmaceuticals Limited (Address: Vill. Sainimajra, Tehsil Nalagarh, Distt. Solan (H. P) - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
20 |
Theosart-25 |
Losartan kali 25mg |
Film coated tablet |
36 months |
USP 38 |
10 packs x 10 tablets container |
VN-22823-21 |
11. Applicant: Vipharco Pharmaceutical Joint Stock Company (Address : 67, Alley 68, Ngọc Thuy Road, Ngoc Thuy Ward, Long Bien District, Hanoi - Vietnam)
11.1 Manufacturer: Mefar Ilac San. A. S. (Address: Ramazanoglu Mah. Ensar Cad. No : 20. Kurtkoy /Pendik Istanbul - Turkey)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
21 |
Dexiren 50mg/2ml |
Dexketoprofen (in form of Dexketoprofen trometamol) 50mg |
Injection, infusion fluid |
24 months |
NSX |
1 pack x 6 tubes of 2 ml container |
VN-22824-21 |
11.2 Manufacture: Nobel Ilac Sanayii Ve Ticaret A.S. (Address: Sancaklar 81100 DUZCE - Turkey)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
22 |
Alrinast 2.5mg/5ml |
Each 1ml of syrup contains: Desloratadin 0,5mg |
Syrup |
24 months |
NSX |
1 bottle x 150 ml container |
VN-22825-21 |
12. Applicant: Tien Phong Pharmaceutical Joint Stock Company (Address: 1/24 Thang Long Road, Ward 4, Tan Binh District, Ho Chi Minh City - Vietnam)
12.1 Manufacturer: Doppel Farmaceutici S.r.l. (Address: Via Martiri delle Foibe, 1-29016 Cortemaggiore-Piacenza - Italy)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
23 |
Traulen |
Every 25g contains Diclofenac sodium 1g |
Topical spray |
24 months |
NSX |
1 spray bottle of 25g container |
VN-22826-21 |
13. Applicant: Gia Hung Pharmaceutical Joint Stock Company (Address: Block 23 of Hamlet 49, Yen Hoa Ward, Cau Giay - Vietnam)
13.1 Manufacturer: B. Braun Medical S.A. (Address: Ronda de los Olivares, Parcela II, Poligono Industrial Los Olivares, 23009 Jean - Spain)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
24 |
Zolenik |
Acid zoledronic (in form of Acid zoledronic monohydrat) 0,8mg/ml |
Concentrate solution mixed with IV fluid |
36 months |
NSX |
1 bottle of 5 ml container |
VN-22827-21 |
14. Applicant: Lamda Pharmaceutical Company Limited (Address: 27/6 Ly Thai To, Thac Gian Ward, Thanh Khe District, Da Nang City - Vietnam)
14.1 Manufacturer: Kern Pharma S.L. (Address: Venus, 72-Poligono Industrial Colon II 08228 Tarrasa (Barcelona) - Spain)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
25 |
Pregabakern 100 mg |
Pregabalin 100 |
Hard capsules |
48 months |
NSX |
6 packs x 14 tablets container |
VN-22828-21 |
|
26 |
Pregabakern 150 mg |
mg Pregabalin 150 |
Hard capsules |
48 months |
NSX |
4 packs x 14 tablets container |
VN-22829-21 |
|
27 |
Pregabakern 25 mg |
mg Pregabalin 25 |
Hard capsules |
48 months |
NSX |
4 packs x 14 tablets container |
VN-22830-21 |
|
28 |
Pregabakern 300 mg |
mg Pregabalin |
Hard capsules |
48 months |
NSX |
4 packs x 14 tablets container |
VN-22831-21 |
|
29 |
Pregabakern 50 mg |
300mg Pregabalin |
Hard capsules |
48 months |
NSX |
4 packs x 14 tablets container |
VN-22832-21 |
|
30 |
Pregabakern 75 mg |
50 mg Pregabalin 75 mg |
Hard capsules |
48 months |
NSX |
4 packs x 14 tablets container |
VN-22833-21 |
14.2 Manufacturer: Labiana Pharmaceuticals, S.L.U (Address: C/Casanova,27-31, Corbera de Llobregat, 08757 Barcelona - Spain)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
31 |
Chamogel |
Natri Colistimethat 1 MIU (80mg) |
Lyophilized powder for injection |
24 months |
NSX |
10 bottle container |
VN-22834-21 |
15. Applicant: New Far East Pharmaceutical Company Limited (Address: 011 Office building H1, Hoang Dieu Road, Ward 9, District 4, Ho Chi Minh City - Vietnam)
15.1 Manufacturer: Sinil Pharm Co., Ltd. (Address: 28, Boksanggol-gil, Angseong-myeon, Chungju-si, Chungcheongbuk-do - Korea)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
32 |
Tourpen |
Flurbiprofen 20 mg |
Plaster |
36 months |
NSX |
50 packs x 7 plasters |
VN-22835-21 |
16. Applicant: Y-Med Pharmaceutical Company Limited (Address: 1-3 Road No. 45, Ward 6, District 4, Ho Chi Minh City - Vietnam)
16.1 Manufacturer: Globela Pharma Pvt. Ltd (Address: 357, GIDC, Sachin, City: Surat-394 230, Dist: Gujarat State - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
33 |
Outenzz 25 |
Losartan potassium 25mg |
Film coated tablet |
36 months |
BP 2019 |
3 packs x 10 tablets container |
VN-22836-21 |
|
34 |
Outenzz 50 |
Losartan potassium 50mg |
Film coated tablet |
36 months |
BP 2019 |
3 packs x 10 tablets container |
VN-22837-21 |
16.2 Manufacturer: S Kant Healthcare Limited (Address: Plot No. 1802-1805, G. I. D. C, Phase III, Vapi 396 195, District Valsad, Gujarat - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
35 |
Betad |
Betamethason (in form of Betamethason dipropionat) 0,05% w/w |
Topical cream |
36 months |
USP 40 |
1 tube of 15 g container |
VN-22838-21 |
|
36 |
Ibukant-400F |
Ibuprofen 400mg |
Film coated tablet |
36 months |
BP 2017 |
10 packs x 10 tablets container |
VN-22839-21 |
|
37 |
Skandid V2 |
Clotrimazole 2 % w/w |
Vaginal cream |
36 months |
USP 42 |
1 tube of 20 g and applicator container |
VN-22840-21 |
|
38 |
Syxten 5% |
Carbocisteine 250mg/5ml |
Syrup |
36 months |
NSX |
1 bottle of 100 ml container |
VN-22841-21 |
16.3 Manufacturer: Swiss Pharma Pvt. Ltd. (Address: 3709, Phase IV, GIDC Vatva, Ahmedabad 382-445, Gụjarat - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
39 |
Finasgen |
Finasteride 5 mg |
Film coated tablet |
36 months |
USP 42 |
10 packs x 10 tablets container |
VN-22842-21 |
17. Applicant: An Phat Single-member Ltd. (Address: 166/42 Thich Quang Duc Road, Ward 4, Phu Nhuan District, Ho Chi Minh City - Vietnam)
17.1 Manufacturer: Karnataka Antibiotics & Pharmaceuticals Limited (Address: No. 14, II Phase, Peenya Industrial Area, Bengaluru 560 058 - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
40 |
Verthin 1000 |
Cephalothin (in form of Cephalothin natri) 1000mg |
Powder for reconstitution |
36 months |
USP39 |
1 bottle container |
VN-22843-21 |
|
41 |
Verthin 2000 |
Cephalothin (in form of Cephalothin natri) 2000mg |
Powder for reconstitution |
36 months |
USP39 |
1 bottle container |
VN-22844-21 |
18. Applicant: Viet Tin Pharmaceutical Company Limited (Address: 64 Le Loi Road, Ward 4, Go Vap District, Ho Chi Minh City - Vietnam)
18.1 Manufacturer: M/s Windlas Biotech Private Limited (Address: Plant-2, Khasra No. 141 to 143 & 145, Mohabewala Industrial Area, Dehradun-248110, Uttarakhand - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
42 |
Corel 75 |
Clopidogrel (in form of clopidogrel bisulfat) 75mg |
Film coated tablet |
24 months |
USP42 |
3 packs x 10 tablets container |
VN-22845-21 |
|
43 |
Olanz-10 |
Olanzapin 10mg |
Film coated tablet |
24 months |
USP41 |
3 packs x 10 tablets container |
VN-22846-21 |
|
44 |
Rasbergy-20 |
Rabeprazol natri 20mg |
Enteric capsule |
24 months |
NSX |
3 packs x 10 tablets container |
VN-22847-21 |
|
45 |
Rosiduc-20 |
Rosuvastatin (in form of rosuvastatin calcium) 20mg |
Film coated tablet |
24 months |
NSX |
3 packs x 10 tablets container |
VN-22848-21 |
|
46 |
Rosiduc-5 |
Rosuvastatin (in form of rosuvastatin calcium) 5mg |
Film coated tablet |
24 months |
NSX |
3 packs x 10 tablets container |
VN-22849-21 |
|
47 |
Salzol |
Salbutamol (in form of salbutamol sulfat) 2mg/5ml |
Oral solution |
24 months |
BP 2019 |
100 ml bottle container |
VN-22850-21 |
19. Applicant: PV Healthcare Pharmaceutical Company Limited (Address: 4/5 Van Xuan Dat Viet Residential area, Road No. 5, Binh Hung Hoa Ward, Binh Tan District, Ho Chi Minh City - Vietnam)
19.1 Manufacturer: The Acme Laboratories Ltd. (Address: Dhulivita, Dhamrai, Dhaka - Bangladesh)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
48 |
Arolox |
Ambroxol hydrochloride 15mg/5ml |
Syrup |
24 months |
NSX |
60 ml bottle container |
VN-22851-21 |
20. Applicant: Nhan Sinh Company Limited (Address: 58 Bau Cat 7 Road, Ward 14, Tan Binh District, Ho Chi Minh City - Vietnam)
20.1 Manufacturer: Aziende Chimiche Riunite Angelini Francesco (ACRAF S.p.A) (Address: Via Vecchia del Pinocchio, 22 60131 Ancona - Italy)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
49 |
Ginetatum vaginal solution 0,1 % |
Benzydamine hydrochloride 0,1% w/v |
Vaginal solution |
48 months |
NSX |
5 bottles x 140ml container |
VN-22852-21 |
21. Applicant: Seamed PTK Company Limited (Address: 61 To Ngoc Van, Quang An Ward, Tay Ho District, Hanoi - Vietnam)
21.1 Manufacturer: PrJSC "Pharmaceutical Firm "Darnitsa" (Address: 13 Boryspilska Street, Kyiv 02093 - Ukraine)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
50 |
Metronidazole-Darnitsa |
Metronidazole 500mg/100ml |
Injection, infusion fluid |
24 months |
NSX |
500 ml bottle container |
VN-22853-21 |
22. Applicant: United International Pharma Company Limited (Address: 16 VSIP II, Road No. 7, KCN Vietnam-Singapore II Industrial Park, Binh Duong Industrial Service and Residential Complex, Hoa Phu Ward, Thu Dau Mot City, Binh Duong Province - Vietnam)
22.1 Manufacturer: Amherst Laboratories, Inc (Address: Unilab Pharma Campus, Barangay Mamplasan, Binan, Laguna - Philippines)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
51 |
Reinin |
Gabapentin 600mg |
Film-coated capsule |
24 months |
NSX |
5 packs x 6 tablets container |
VN-22854-21 |
23. Applicant: Viet Gate Medical Company Limited (Address: 788/2B Nguyen Kiem, Ward 3, Go Vap District, Ho Chi Minh City - Vietnam)
23.1 Manufacturer: Titan Laboratories Pvt. Ltd (Address: Plot No. E-27/1, E-27/2, M. I. D. C., Mahad, Village - Jite, Raigad 402309, Maharashtra State - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
52 |
Itracon |
Itraconazole 100 mg |
Hard capsules |
24 months |
NSX |
10 packs x 10 tablets container |
VN-22855-21 |
|
53 |
Loficor |
Fenofibrat 200 mg |
Hard capsules |
24 months |
USP 38 |
3 packs x 10 tablets container |
VN-22856-21 |
24. Applicant: EA Pharma Company Limited (Address: 1-1, Irifune 2-chome, Chou-ku, Tokyo - Japan)
24.1 Manufacturer: Ay Pharmaceuticals Co., Ltd. (Address: 235, Miyakami, Shimizu-ku, Shizuoka-shi, Shizuoka - Japan)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
54 |
Aminic |
Each 200ml pack contains: L-Isoleucin 1,820g; L-Leucin 2,580g; L-Lysin acetat 2,000g; L-Methionin 0,880g; L-Phenylalanin 1,400g; L-Threonin 1,500g; L-Tryptophan 0,260g; L-Valin 2,800g; L-Alanin 1,420g; L-Arginin 1,800g; L-Aspartic acid 0,200g; L-Cystein 0,070g; L-Glutamic acid 0,100g; L-Histidin 1,000g; L-Prolin 1,000g; L-Serin 0,340g; L-Tyrosin 0,080g; Glycin 1,400g |
Injection, IV infusion fluid |
36 months |
NSX |
200 ml pack |
VN-22857-21 |
25. Applicant: Il-Yang Pharm Company Limited (Address: (Hagal-dong), 110, Hagal-ro, Giheung-gu Yongin-si, Gyeonggi-do - Korea)
25.1 Manufacturer: AhnGook Pharmaceutical Company, Limited (Address: 40, Jeyakgongdan 1-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do - Korea)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
55 |
Dispeptin |
Mosapride Citrate (in form of Mosapride Citrate dihydrate) 5mg |
Film coated tablet |
36 months |
JP 17 |
3 packs x 10 tablets container |
VN-22858-21 |
26. Applicant: Laboratories Aguettant (Address: No1 rue Alexander Fleming, Lyon 69007 - France)
26.1 Manufacturer: Laboratoire Aguettant (Address: Lieu-Dit “Chantecaille” - Champagne 07340 - France)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
56 |
Nutryelt |
Zinc gluconat 69700,000mcg; Copper gluconat 2142,400 mcg; Mangan gluconat 445,690 mcg; Sodium fluorid 2099,500 mcg; Potassium iodid 170,060 mcg; Sodium selenit 153,320 mcg; Sodium molỵbdat 42,930 mcg; Crom clorid 30,450 mcg; Ferrous gluconat 7988,200 mcg; |
Concentrate solution for infusion |
36 months |
NSX |
10 tubes x 10 ml container |
VN-22859-21 |
27. Applicant: Micro Labs Limited (Address: No. 31, Race Course Road, Bengaluru 5600 01, Kamataka - India)
27.1 Manufacturer: Micro Labs Limited (Address: 92, Sipcot Industrial complex, Hosur-635 126, Tamil Nadu - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
57 |
Opelan-10 |
Olanzapine 10mg |
Film coated tablet |
36 months |
USP 40 |
10 packs x 10 tablets container |
VN-22860-21 |
|
58 |
Opelan-5 |
Olanzapine 5mg |
Film coated tablet |
36 months |
USP 40 |
10 packs x 10 tablets container |
VN-22861-21 |
|
59 |
Xonadin-180 |
Fexofenadin hydrochlorid 180mg |
Film coated tablet |
36 months |
USP 41 |
1 packs x 10 tablets container |
VN-22862-21 |
28. Applicant: Nomura Trading Company Limited (Address: 7-3, Azuchi-machi, 1-Chome, Chuo-ku, Osaka - Japan)
28.1 Manufacturer: Covalent Laboratories Private Limited (Address: Survey No.: 374, Gundla Machanoor Village Hathnoor Mandal, Sangareddy Dist- 502 296. Telangana State - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
60 |
Cefixime USP |
Ingredient Cefixim |
Ingredient |
36 months |
USP40 |
25kg barrel |
VN-22863-21 |
29. Applicant: PT. Novell Pharmaceutical Laboratories (Address: Jl. Wanaherang No. 35, Tlajung Udik, Gunung Putri, Bogor 16962 - Indonesia)
29.1 Manufacturer: PT. Novell Pharmaceutical Laboratories (Address: Jl. Wanaherang No. 35, Tlajung Udik, Gunung Putri, Bogor 16962 - Indonesia)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
61 |
Novexib 200 |
Celecoxib 200mg |
Hard capsules |
36 months |
NSX |
3 packs x 10 tablets container |
VN-22864-21 |
|
62 |
Panvell |
Pantoprazol (in form of pantoprazol natri sesquihydrat) 40mg |
Lyophilized powder for injection |
24 months |
BP2019 |
1 bottle container |
VN-22865-21 |
30. Applicant: S.C. Antibiotice S. A. (Address: 1th Valea Lupului Street, Zip Code 707410, Iasi - Rumani)
30.1 Manufacturer: S.C. Antibiotice S. A. (Address: 1th Valea Lupului Street, Zip Code 707410, Iasi - Rumani)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
63 |
Effixent |
Cefixime (in form of Cefixime trihydrat) 200mg |
Hard capsules |
36 months |
NSX |
1 pack x 10 tablets container, 10 packs x 10 tablets container, 100 packs x 10 tablets container |
VN-22866-21 |
31. Applicant: Saint Corporation (Address: Academy Tower, Rm #718, 719, 118 Seongsui-ro, Seongdong-gu, Seoul - Korea)
31.1 Manufacturer: Korea Prime Pharm. Company Limited (Address: 100, Wanjusandan 9-ro, Bongdong-eup, Wanju-Gun, Jeollabuk-do - Korea)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
64 |
Melevox |
Levofloxacin (in form of Levofloxacin hydrat) 500mg |
Film coated tablet |
36 months |
NSX |
3 packs x 10 tablets container |
VN-22867-21 |
32. Applicant: Unison Laboratories Company Limited (Address: 39 Moo 4, Klong Udomcholjorn, Muang Chachoengsao, Chachoengsao 24000 - Thailand)
32.1 Manufacturer: Unison Laboratories Company Limited (Address: 39 Moo 4, Klong Udomcholjorn, Muang Chachoengsao, Chachoengsao 24000 - Thailand)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
65 |
Otuna 2.5% |
Selenium sulfid 2,5g/100ml |
Shampoo |
36 months |
USP 38 |
100 ml HDPE plastic bottle |
VN-22868-21 |
|
66 |
Quantia 200 |
Quetiapine (in form of quetiapine fumarate) 200mg |
Tablet |
24 months |
NSX |
1 bag of 3 packs x 10 tablets |
VN-22869-21 |
LIST OF 17 FOREIGN MEDICINES ISSUED WITH MARKETING
AUTHORIZATION FOR 3 YEARS - 2ND REVISION OF THE 105TH
EDITION
(Attached to Decision No. 490/QD-QLD, dated August 4, 2021)
1. Applicant: Accord Healthcare Limited (Address: Ground Floor, Sage House, 319 Pinner Road, North Harrow, Middlesex HA1 4HF - United Kingdom)
1.1 Manufacturer: Intas Pharmaceuticals Limited (Address: Plot No. 457, 458, Village-Matoda, Bavla Road, And Plot No: 191/218 P, Village: Chacharwadi,Ta:-Sanand, Dist. -Ahmedabad - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
1 |
Calutas 50 |
Bicalutamide 50mg |
Film coated tablet |
36 months |
USP40 |
3 packs x 10 tablets container |
VN3-328-21 |
|
2 |
Letrotas 2.5 |
Letrozol 2,5mg |
Film coated tablet |
36 months |
USP38 |
3 packs x 10 tablets container |
VN3-329-21 |
2. Applicant: APC Pharmaceuticals & Chemical Limited (Address: Suite 2102, 21/F Wing on centre, 111 Connaught Road, Central - Hong Kong)
2.1 Manufacturer: Atra Pharmaceuticals Limited (Address: Plot No. H19, MIDC Area Waluj Aurangabad 431133, Maharashtra State - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
3 |
Tenofovir Disoproxil Fumarate 300mg + Lamivudine 100mg Tablets |
Tenofovir disoproxil fumarat 300mg; Lamivudine 100mg |
Film coated tablet |
24 months |
NSX |
1 packs x 10 tablets container |
VN3-330-21 |
3. Applicant: AstraZeneca Singapore Pte., Limited (Address: 10, Kallang Avenue #12-10 Aperia, Singapore 339510 - Singapore)
3.1 Manufacturer: AstraZeneca UK Limited (Address: Silk Road Business Park, Macclesfield, Cheshire, SK10 2NA - UK)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
4 |
Zoladex |
Goserelin (in form of goserelin acetat) 10,8mg |
Injected subcutaneous implant for extended release |
24 months |
NSX |
Container of 1 single-use syringe containing subcutaneous implant for extended release |
VN3-331-21 |
4. Applicant: Pharmatopes Viet Nam Joint Stock Company (Address: 5 Nguyen Truong To, Nguyen Trung Truc Ward, Ba Dinh District, Hanoi - Vietnam)
4.1 Manufacturer: Mefar Ilac San. A. S. (Address: Ramazanoglu Mah. Ensar Cad. No : 20. Kurtkoy /Pendik Istanbul - Turkey)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
5 |
MON.MDP KIT |
Methylenediphosph onic acid (MDP) 10mg |
Lyophilized powder for injection |
24 months |
NSX |
5 bottle container |
VN3-332-21 |
|
6 |
MON.MIBI.KIT |
Tetrakis (2-methoxy isobutyl isonitrile) copper (I) tetrafluoroborate 1mg |
Lyophilized powder for injection |
24 months |
NSX |
5 bottle container |
VN3-333-21 |
5. Applicant: Sohaco Trading & Pharmaceutical Group Joint Stock Company (Address: 5 Lang Ha, Ba Dinh, Hanoi - Vietnam)
5.1 Manufacturer: Max Zeller Söhne AG (Address: Seeblickstrasse 4, 8590 Romanshom - Switzerland)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
7 |
Remotiv 500 |
St John’s wort dry extract mixed with 57.9% Ethanol (v/v) in [(4-7):1] ratio 500 mg |
Film coated tablet |
24 months |
NSX |
3 packs x 10 tablets container |
VN3-334-21 |
6. Applicant: Bach Viet Pharmaceutical Company Limited (Address: 146, 230 Alley of Dinh Cong Thuong, Dinh Cong Ward, Hoang Mai District, Hanoi - Vietnam)
6.1 Manufacturer: Actavis Italy S.p.A. (Address: Via Pasteur, 10-20014, Nerviano, (MI) - Italy)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
8 |
Gemcitabine Invagen 40mg/ml |
Every 1ml of concentrate solution contains: Gemcitabin (in form of Gemcitabin hydrochlorid) 40mg |
Concentrate solution for IV infusion |
18 months |
EP 8.6 |
1 bottle of 50 ml container |
VN3-335-21 |
7. Applicant: An Phat Single-member Limited Company (Address: 166/42 Thich Quang Duc Road, Ward 4, Phu Nhuan District, Ho Chi Minh City - Vietnam)
7.1 Maufacturer: Precise Chemipharma Private Limited Company (Address: Gut No. 215/1 & 215/2, Khatwad Phata, At Post Talegaon, Taluka Dindori, Nashik 422202 Maharashtra State - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
9 |
Agosys |
Agomelatine 25mg |
Film coated tablet |
24 months |
NSX |
1 pack x 10 tablets container, 3 packs x 10 tablets container |
VN3-336-21 |
7.2 Manufacturer: Venus Remedies Limited (Address: Hill Top Industrial Estate, Jharmajari EPIP, Phase-I (ext), Bhatoli Kalan, Baddi, Dist. Solan, Himachal Pradesh, 173205 - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
10 |
Venobicin |
Epirubicin hydroclorid 10 mg |
Lyophilized powder for injection |
24 months |
NSX |
1 bottle container |
VN3-337-21 |
8. Applicant: Merck Sharp & Dohme (Asia) Limited (Address: 27/F., Lee Garden Two, 28 Yun Ping Road, Causeway Bay - Hong Kong)
8.1 Manufacturer: Alkermes Pharma Ireland Limited Company (Address: Monksland, Athlone, Co. Westmeath, N37 EA09 - Ireland)
Packaging and release faciltiy: Merck Sharp & Dohme B.V. (Address: Warrderweg 39, Haarlem, 2031 BN, Netherlands)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
11 |
Emend |
Aprepitant 80mg & 125mg |
Hard capsules |
24 months |
NSX |
1 pack of 1 capsule of 125 mg and 2 capsules of 80 mg. Expiration date of the kit follows the shortest expiration dates |
VN3-338-21 |
9. Applicant: MI Pharma Private Limited (Address: Unit No. 402 & 403, Viva Hub Town, Shankar Wadi, Village Mogra, Jogeshwari East, Mumbai - 400060 - India)
9.1 Manufacturer: Mylan Laboratories Limited [OTL] (Address: Plot No. 284B, Bommasandra - Jigani link road, Industrial area, Anekal Taluk, Bangalore - 560 105 - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
12 |
Bendamustine Mylan |
Bendamustin hydrochlorid 25mg |
Lyophilized powder for injection |
24 months |
NSX |
1 bottle container |
VN3-339-21 |
|
13 |
Carboplatin Mylan |
Every 1ml solution contains: Carboplatin 10mg |
Injection liquid |
24 months |
NSX |
1 bottle container |
VN3-340-21 |
|
14 |
Docetaxel Mylan |
Every 1ml solution contains: Docetaxel anhydrous 10mg |
Injection, infusion fluid |
24 months |
NSX |
1 bottle container |
VN3-341-21 |
10. Applicant: Naprod Life Sciences Private Limited (Address: 304, Town Centre, Andheri kurla Road, Andheri (E), Mumbai, Maharastra, 400059 - India)
10.1 Manufacturer: Naprod Life Sciences Private Limited (Address: G-17/1, MIDC, Tarapur, Industrial Area, Boisar, Dist. Thane-401506 - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
15 |
Naprolat |
Carboplatin 10mg/ml |
Injection, infusion fluid |
24 months |
BP2018 |
1 bottle of 15 ml container |
VN3-342-21 |
11. Applicant: Panacea Biotec Pharma Limited (Address: B-1 Extension/A-27, Mohan Co-operative Industrial Estate, Mathura Road, New Delhi- South Delhi DL 110044 - India)
11.1 Manufacturer: M/s Panacea Biotec Pharma Limited (Address: Malpur, Baddi, Distt. Solan HP-173205 - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
16 |
Glizym-M |
Gliclazide 80mg; Metformin hydrochloride 500mg |
Tablet |
36 months |
NSX |
20 packs x 10 tablets container |
VN3-343-21 |
12. Applicant: Sun Pharmaceutical Industries Limited (Address: UB Ground, 5 & AMP; 6th floors, Sun House, CTS No. 201, B/1, Ram Nagar, Western Express Highway, Goregaon East, Mumbai, 400063, Maharashtra - India)
12.1 Manufacturer: Sun Pharmaceutical Industries Limited (Address: Halol-Baroda Highway, Halol-389 350, Dist. Panchmahal, Gujarat State - India)
|
No. |
Name |
Primary active ingredient - Content |
Dosage form |
Shelf life |
Standards |
Packaging method |
Registration number |
|
17 |
Bestane |
Exemestane (micronized) 25 mg |
Film coated tablet |
24 months |
NSX |
1 packs x 14 tablets container |
VN3-344-21 |
------------------------------------------------------------------------------------------------------
This translation is made by THƯ VIỆN PHÁP LUẬT, Ho Chi Minh City, Vietnam and
for reference purposes only. Its copyright is owned by THƯ VIỆN PHÁP LUẬT
and protected under Clause 2, Article 14 of the Law on Intellectual Property.Your comments are always welcomed

